With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development of medicines.

This article provides examples of how AI is helping to shape drug discovery, from drug design through to clinical trials.

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, today announced it has entered into a strategic partnership with ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement ... relying on a checkbox approach with extensive testing at each step of the process.

Signet begins patient dosing in phase I trial in China for SIGX1094 to treat diffuse gastric cancer and other advanced solid tumours: New York Thursday, January 16, 2025, 14:00 Hr ...

Insilico Medicine ('Insilico'), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today announces positive results from two Phase I studies in ...